ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
General Outlook
In simple terms, ImpediMed Limited has 2023.25 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.837% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.052%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.894%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.339% return, is a testament to ImpediMed Limited's adeptness in optimizing resource deployment. ImpediMed Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.519%. Furthermore, the proficiency of ImpediMed Limited in capital utilization is underscored by a remarkable -0.419% return on capital employed.
Stock Prices
ImpediMed Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.08, while its low point bottomed out at $0.08. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ImpediMed Limited's stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”